Tursynay Issabekova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tursynay Issabekova has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra Foksinska
Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham
1 shared publication - Anath Shalev
Comprehensive Diabetes Center and Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham
1 shared publication - Andrew Crouse
Hugh Kaul Precision Medicine Institute, University of Alabama at Birmingham
1 shared publication - Andrew I. Su
The Scripps Research Institute
1 shared publication - Anne E. Thessen
The University of North Carolina at Chapel Hill
1 shared publication Basazin Belhu
Institute for Systems Biology, Seattle, WA, USA
1 shared publication
Latest Publications
- Open Access
- 14 September 2023
- Published by Cambridge University Press (CUP) in Journal of Clinical and Translational Science
- Vol. 7 (1) , 1-24
An approach for collaborative development of a federated biomedical knowledge graph-based question-answering system: Question-of-the-Month challenges
Knowledge graphs have become a common approach for knowledge representation. Yet, the application of graph methodology is elusive due to the sheer number and complexity of knowledge sources. In addition, semantic incompatibilities hinder efforts to harmonize and integrate across these diverse sources. As part of The Biomedical Translator Consortium, we have developed a knowledge graph–based question-answering system designed to augment human reasoning and accelerate translational scientific discovery: the Translator system. We have applied the Translator system to answer biomedical questions in the context of a broad array of diseases and syndromes, including Fanconi anemia, primary ciliary dyskinesia, multiple sclerosis, and others. A variety of collaborative approaches have been used to research and develop the Translator system. One recent approach involved the establishment of a monthly “Question-of-the-Month (QotM) Challenge” series. Herein, we describe the structure of the QotM Challenge; the six challenges that have been conducted to date on drug-induced liver injury, cannabidiol toxicity, coronavirus infection, diabetes, psoriatic arthritis, and ATP1A3-related phenotypes; the scientific insights that have been gleaned during the challenges; and the technical issues that were identified over the course of the challenges and that can now be addressed to foster further development of the prototype Translator system. We close with a discussion on Large Language Models such as ChatGPT and highlight differences between those models and the Translator system.
- 14 September 2023
- Published by Cambridge University Press (CUP) in Journal of Clinical and Translational Science
- Vol. 7 (1) , 1-24
Open AccessAn approach for collaborative development of a federated biomedical knowledge graph-based question-answering system: Question-of-the-Month challenges
Knowledge graphs have become a common approach for knowledge representation. Yet, the application of graph methodology is elusive due to the sheer number and complexity of knowledge sources. In addition, semantic incompatibilities hinder efforts to harmonize and integrate across these diverse sources. As part of The Biomedical Translator Consortium, we have developed a knowledge graph–based question-answering system designed to augment human reasoning and accelerate translational scientific discovery: the Translator system. We have applied the Translator system to answer biomedical questions in the context of a broad array of diseases and syndromes, including Fanconi anemia, primary ciliary dyskinesia, multiple sclerosis, and others. A variety of collaborative approaches have been used to research and develop the Translator system. One recent approach involved the establishment of a monthly “Question-of-the-Month (QotM) Challenge” series. Herein, we describe the structure of the QotM Challenge; the six challenges that have been conducted to date on drug-induced liver injury, cannabidiol toxicity, coronavirus infection, diabetes, psoriatic arthritis, and ATP1A3-related phenotypes; the scientific insights that have been gleaned during the challenges; and the technical issues that were identified over the course of the challenges and that can now be addressed to foster further development of the prototype Translator system. We close with a discussion on Large Language Models such as ChatGPT and highlight differences between those models and the Translator system.